A detailed history of Gagnon Securities LLC transactions in Bio Techne Corp stock. As of the latest transaction made, Gagnon Securities LLC holds 7,369 shares of TECH stock, worth $525,262. This represents 0.12% of its overall portfolio holdings.

Number of Shares
7,369
Previous 7,116 3.56%
Holding current value
$525,262
Previous $509,000 15.52%
% of portfolio
0.12%
Previous 0.12%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$70.96 - $82.35 $17,952 - $20,834
253 Added 3.56%
7,369 $588,000
Q2 2024

Aug 14, 2024

BUY
$62.12 - $84.15 $5,093 - $6,900
82 Added 1.17%
7,116 $509,000
Q1 2024

May 13, 2024

BUY
$65.98 - $77.09 $143,176 - $167,285
2,170 Added 44.61%
7,034 $495,000
Q4 2023

Feb 14, 2024

BUY
$52.83 - $78.22 $49,237 - $72,901
932 Added 23.7%
4,864 $375,000
Q3 2023

Nov 14, 2023

BUY
$67.52 - $89.42 $265,488 - $351,599
3,932 New
3,932 $267,000

Others Institutions Holding TECH

About BIO-TECHNE Corp


  • Ticker TECH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,222,600
  • Market Cap $2.8B
  • Description
  • Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...
More about TECH
Track This Portfolio

Track Gagnon Securities LLC Portfolio

Follow Gagnon Securities LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gagnon Securities LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gagnon Securities LLC with notifications on news.